Biotechnology Reagents Market Report and Forecast 2025-2034
Description
The global biotechnology reagents market size was valued at USD 34.10 Billion in 2024, driven by increasing innovations and funding activities. The market size is anticipated to grow at a CAGR of 8.03% during the forecast period of 2025-2034 to achieve a value of USD 73.82 Billion by 2034.
Global Biotechnology Reagents Market Overview
Biotechnology reagents are used in biotechnological procedures to enable certain reactions, analyses, or manipulations within biological systems. These reagents are substances and compounds that play a crucial role in several lab procedures, experiments, and industrial applications associated with biotechnology. They can include a wide range of molecules, compounds, enzymes, buffers, antibodies, nucleic acids, and other materials necessary for tasks such as DNA amplification, protein analysis, cell culture, purification, sequencing, and more.
Biotechnology reagents are extremely useful in research and experiments related to fields such as fields like molecular biology, genetics, biochemistry, pharmaceuticals, and agriculture. Several types of biotechnology reagents can be categorized based on their applications. For instance, molecular biology techniques like PCR (Polymerase Chain Reaction) require reagents such as DNA polymerases, primers, nucleotides, and buffers.
The biotechnology reagents market growth is driven by certain factors such as increased research and development activities. Increasing investments by pharmaceutical companies to research more to find new reagents or explore the full potential of existing reagents. The market is further driven by the increasing interest of market players in stem cell research, and a rise in the number of biotechnology firms. The increasing research activities by pharmaceutical companies to develop new drugs are collectively contributing to market growth. Due to the increased drug development research activities, and number of clinical trials are simultaneously expected to increase and drive market growth in the forecast period.
Latest Launches in the Market to Drive the Biotechnology Reagents Market Demand
The market growth is driven by innovative launches backed by research and investments by the market key players exemplified by the recent launch of a new antibody by Aalto Bio Reagents in May 2023. They have launched their new Mouse Monoclonal Antibody (MAb) to Cholera Toxin B (CM 1431) in response to the escalating cholera outbreak in Africa and southern Asia, as well as a growing risk of a cholera outbreak in the Ukraine . Such developments can result in a brand-new revolution in the market with widespread applications in various fields, propelling the market growth in the forecast period.
Adaptation of Advanced Technologies to Drive the Growth
The market is further expected to be influenced by the increased adoption of advanced technologies. For instance, Biotech companies have started to deploy advanced technologies such as artificial intelligence (AI) to streamline a variety of operational processes via enhanced automation. With the integration of AI in these procedures, the identification of biomarkers that have applications for the development of drugs and diagnostics has become convenient, bolstering global biotechnology reagents market growth.
Research and Studies to Contribute to the Growing Market Size
The market is expected to witness significant growth in the forecast period driven by continuous efforts of key players towards making discoveries associated with market expansion. For instance, the recent innovation of a revolutionary recycling process technology to extract pure polypropylene (PP) from PCR multilayer packaging waste, currently hard to recycle, has been announced by Braskem. Braskem is a leading polyolefins producer in America and a leading producer of biopolymers globally. Braskem also mentioned that they have been awarded funding amounting to USD 600,000. This is a Research, Demonstration, and Development (RD&D) grant from the Reducing Embodied Energy and Decreasing Emissions (REMADE) Institute, a public-private partnership established by the United States Department of Energy (DOE) . Such announcements and funding activities are major factors aiding the biotechnology reagents market size as the procedure performing required activities will eventually require reagents to perform the activity efficiently.
Strategic Collaborations between Key Players to Aid the Market Growth
In May 2023, to continue providing the highest quality laboratory services and state-of-the-art technologies, FlowMetric collaborated directly with Cytek™Biosciences in providing feedback on the pre-designed panels associated with their next generation of flow cytometric instrumentation. Such strategic collaborations are expected to attract researchers and laboratories seeking innovative tools, and individuals preferring high-quality services, further bolstering the global biotechnology reagents market demand.
The Cytek Aurora harnesses full spectrum technology, offering remarkable flexibility and stability. It allows for a diverse range of new fluorochrome combinations without requiring system reconfiguration for each specific application. This system provides high-resolution data at the individual cell level, effectively addressing complex challenges like cells exhibiting high autofluorescence or limited expression of crucial biomarkers, irrespective of the assay's complexity.
Global Biotechnology Reagents Market Segmentations
Biotechnology Reagents Market Report and Forecast 2025-2034 offers a detailed analysis of the market based on the following segments:
Market Breakup by Technology PCR
Cell Culture
Hematology
In-vitro Diagnostics
Other Technologies Chromatography
Mass Spectrometry
Electrophoresis
Flow Cytometry
Other Analytical Reagents
Market Breakup by Applications
North America is dominating the global market with increasing activities related to drug development and research dedicated to exploring the full potential of existing reagents, associated with the increasing competition among market players. This may further increase the demand for new reagents with widespread applications and enhanced performance resulting in continuous dominance of North America in the forecast period.
Rising collaborations for better innovations are likely to aid the biotechnology reagents market growth in the coming years. In September 2023, Navigate BioPharma and Becton Dickinson strategically collaborated to use flow cytometry to develop and commercialize companion diagnostics (CDx) and clinical decision-making solutions. Navigate BioPharma, an independently operating subsidiary of Novartis, provides biomarker and bioanalytic solutions for clinical development and CDx applications. The collaboration harnesses Navigate BioPharma's experience in designing and validating biomarker assays with BD’s expertise in flow cytometry and development services.
With this collaboration, the combination of Navigate BioPharma's proficiency in biomarker assays and CDx applications with BD’s specialized knowledge in flow cytometry, and development services is expected to result in a powerful synergy. This may potentially lead to the development of innovative solutions, further bolstering the market growth.
Global Biotechnology Reagents Market: Competitor Landscape
In May 2023, Bio-Rad Laboratories, Inc., a global leader in life science research and clinical diagnostic products, announced the launch of the IH-500TM NEXT System, a fully automated system for ID-Cards. Bio-Rad is one of the world's most respected suppliers of blood screening systems, serving blood banks and transfusion centers globally for over 70 years. In an evolving environment, with the IH-500 NEXT System, Bio-Rad offers enhanced benefits to address the current and future needs of laboratories.
The key features of the biotechnology reagents market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
*Please Note:* The report will take 5 business days to complete, after order confirmation.
Global Biotechnology Reagents Market Overview
Biotechnology reagents are used in biotechnological procedures to enable certain reactions, analyses, or manipulations within biological systems. These reagents are substances and compounds that play a crucial role in several lab procedures, experiments, and industrial applications associated with biotechnology. They can include a wide range of molecules, compounds, enzymes, buffers, antibodies, nucleic acids, and other materials necessary for tasks such as DNA amplification, protein analysis, cell culture, purification, sequencing, and more.
Biotechnology reagents are extremely useful in research and experiments related to fields such as fields like molecular biology, genetics, biochemistry, pharmaceuticals, and agriculture. Several types of biotechnology reagents can be categorized based on their applications. For instance, molecular biology techniques like PCR (Polymerase Chain Reaction) require reagents such as DNA polymerases, primers, nucleotides, and buffers.
The biotechnology reagents market growth is driven by certain factors such as increased research and development activities. Increasing investments by pharmaceutical companies to research more to find new reagents or explore the full potential of existing reagents. The market is further driven by the increasing interest of market players in stem cell research, and a rise in the number of biotechnology firms. The increasing research activities by pharmaceutical companies to develop new drugs are collectively contributing to market growth. Due to the increased drug development research activities, and number of clinical trials are simultaneously expected to increase and drive market growth in the forecast period.
Latest Launches in the Market to Drive the Biotechnology Reagents Market Demand
The market growth is driven by innovative launches backed by research and investments by the market key players exemplified by the recent launch of a new antibody by Aalto Bio Reagents in May 2023. They have launched their new Mouse Monoclonal Antibody (MAb) to Cholera Toxin B (CM 1431) in response to the escalating cholera outbreak in Africa and southern Asia, as well as a growing risk of a cholera outbreak in the Ukraine . Such developments can result in a brand-new revolution in the market with widespread applications in various fields, propelling the market growth in the forecast period.
Adaptation of Advanced Technologies to Drive the Growth
The market is further expected to be influenced by the increased adoption of advanced technologies. For instance, Biotech companies have started to deploy advanced technologies such as artificial intelligence (AI) to streamline a variety of operational processes via enhanced automation. With the integration of AI in these procedures, the identification of biomarkers that have applications for the development of drugs and diagnostics has become convenient, bolstering global biotechnology reagents market growth.
Research and Studies to Contribute to the Growing Market Size
The market is expected to witness significant growth in the forecast period driven by continuous efforts of key players towards making discoveries associated with market expansion. For instance, the recent innovation of a revolutionary recycling process technology to extract pure polypropylene (PP) from PCR multilayer packaging waste, currently hard to recycle, has been announced by Braskem. Braskem is a leading polyolefins producer in America and a leading producer of biopolymers globally. Braskem also mentioned that they have been awarded funding amounting to USD 600,000. This is a Research, Demonstration, and Development (RD&D) grant from the Reducing Embodied Energy and Decreasing Emissions (REMADE) Institute, a public-private partnership established by the United States Department of Energy (DOE) . Such announcements and funding activities are major factors aiding the biotechnology reagents market size as the procedure performing required activities will eventually require reagents to perform the activity efficiently.
Strategic Collaborations between Key Players to Aid the Market Growth
In May 2023, to continue providing the highest quality laboratory services and state-of-the-art technologies, FlowMetric collaborated directly with Cytek™Biosciences in providing feedback on the pre-designed panels associated with their next generation of flow cytometric instrumentation. Such strategic collaborations are expected to attract researchers and laboratories seeking innovative tools, and individuals preferring high-quality services, further bolstering the global biotechnology reagents market demand.
The Cytek Aurora harnesses full spectrum technology, offering remarkable flexibility and stability. It allows for a diverse range of new fluorochrome combinations without requiring system reconfiguration for each specific application. This system provides high-resolution data at the individual cell level, effectively addressing complex challenges like cells exhibiting high autofluorescence or limited expression of crucial biomarkers, irrespective of the assay's complexity.
Global Biotechnology Reagents Market Segmentations
Biotechnology Reagents Market Report and Forecast 2025-2034 offers a detailed analysis of the market based on the following segments:
Market Breakup by Technology
- Life Science Reagents
- Analytical Reagents
Market Breakup by Applications
- Protein Synthesis and Purification
- Gene Expression
- DNA and RNA Analysis
- Drug Testing
- Others
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
North America is dominating the global market with increasing activities related to drug development and research dedicated to exploring the full potential of existing reagents, associated with the increasing competition among market players. This may further increase the demand for new reagents with widespread applications and enhanced performance resulting in continuous dominance of North America in the forecast period.
Rising collaborations for better innovations are likely to aid the biotechnology reagents market growth in the coming years. In September 2023, Navigate BioPharma and Becton Dickinson strategically collaborated to use flow cytometry to develop and commercialize companion diagnostics (CDx) and clinical decision-making solutions. Navigate BioPharma, an independently operating subsidiary of Novartis, provides biomarker and bioanalytic solutions for clinical development and CDx applications. The collaboration harnesses Navigate BioPharma's experience in designing and validating biomarker assays with BD’s expertise in flow cytometry and development services.
With this collaboration, the combination of Navigate BioPharma's proficiency in biomarker assays and CDx applications with BD’s specialized knowledge in flow cytometry, and development services is expected to result in a powerful synergy. This may potentially lead to the development of innovative solutions, further bolstering the market growth.
Global Biotechnology Reagents Market: Competitor Landscape
In May 2023, Bio-Rad Laboratories, Inc., a global leader in life science research and clinical diagnostic products, announced the launch of the IH-500TM NEXT System, a fully automated system for ID-Cards. Bio-Rad is one of the world's most respected suppliers of blood screening systems, serving blood banks and transfusion centers globally for over 70 years. In an evolving environment, with the IH-500 NEXT System, Bio-Rad offers enhanced benefits to address the current and future needs of laboratories.
The key features of the biotechnology reagents market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
- Abbott
- Agilent Technologies Inc.
- Danaher
- BD
- Bio-Rad Laboratories Inc.
- General Electric
- bioMérieux SA
- LONZA
- F. Hoffmann-La Roche Ltd.
- Hoefer, Inc.
- PerkinElmer Inc.
- Merck KGaA
- Promega Corporation
- Quality Biological
- Siemens
- Bio-Techne
- TAKARA HOLDINGS INC.
- Sysmex Corporation
- Tosoh Corporation
- Olympus Corporation
*Please Note:* The report will take 5 business days to complete, after order confirmation.
Table of Contents
350 Pages
- 1 Preface
- 1.1 Objectives of the Study
- 1.2 Key Assumptions
- 1.3 Report Coverage – Key Segmentation and Scope
- 1.4 Research Methodology
- 2 Executive Summary
- 3 Global Biotechnology Reagents Market Overview
- 3.1 Global Biotechnology Reagents Market Historical Value (2018-2024)
- 3.2 Global Biotechnology Reagents Market Forecast Value (2025-2034)
- 4 Global Biotechnology Reagents Market Landscape
- 4.1 Global Biotechnology Reagents Developers Landscape
- 4.1.1 Analysis by Year of Establishment
- 4.1.2 Analysis by Company Size
- 4.1.3 Analysis by Region
- 4.2 Global Biotechnology Reagents Product Landscape
- 4.2.1 Analysis by Type
- 4.2.2 Analysis by Technology
- 4.2.3 Analysis by Applications
- 5 Global Biotechnology Reagents Market Dynamics
- 5.1 Market Drivers and Constraints
- 5.2 SWOT Analysis
- 5.3 Porter’s Five Forces Model
- 5.4 Key Demand Indicators
- 5.5 Key Price Indicators
- 5.6 Industry Events, Initiatives, and Trends
- 5.7 Value Chain Analysis
- 6 Global Biotechnology Reagents Market Segmentation
- 6.1 Global Biotechnology Reagents Market by Technology
- 6.1.1 Market Overview
- 6.1.2 Life Science Reagents
- 6.1.2.1 PCR
- 6.1.2.2 Cell Culture
- 6.1.2.3 Hematology
- 6.1.2.4 In-vitro Diagnostics
- 6.1.2.5 Other Technologies
- 6.1.3 Analytical Reagents
- 6.1.3.1 Chromatography
- 6.1.3.2 Mass Spectrometry
- 6.1.3.3 Electrophoresis
- 6.1.3.4 Flow Cytometry
- 6.1.3.5 Other Analytical Reagents
- 6.2 Global Biotechnology Reagents Market by Applications
- 6.2.1 Market Overview
- 6.2.2 Protein Synthesis and Purification
- 6.2.3 Gene Expression
- 6.2.4 DNA and RNA Analysis
- 6.2.5 Drug Testing
- 6.2.6 Others
- 6.3 Global Biotechnology Reagents Market by Region
- 6.3.1 Market Overview
- 6.3.2 North America
- 6.3.3 Europe
- 6.3.4 Asia Pacific
- 6.3.5 Latin America
- 6.3.6 Middle East and Africa
- 7 North America Biotechnology Reagents Market
- 7.1 Market Share by Country
- 7.2 United States of America
- 7.3 Canada
- 8 Europe Biotechnology Reagents Market
- 8.1 Market Share by Country
- 8.2 United Kingdom
- 8.3 Germany
- 8.4 France
- 8.5 Italy
- 8.6 Others
- 9 Asia Pacific Biotechnology Reagents Market
- 9.1 Market Share by Country
- 9.2 China
- 9.3 Japan
- 9.4 India
- 9.5 ASEAN
- 9.6 Others
- 10 Latin America Biotechnology Reagents Market
- 10.1 Market Share by Country
- 10.2 Brazil
- 10.3 Argentina
- 10.4 Mexico
- 10.5 Others
- 11 Middle East and Africa Biotechnology Reagents Market
- 11.1 Market Share by Country
- 11.2 Saudi Arabia
- 11.3 United Arab Emirates
- 11.4 Nigeria
- 11.5 South Africa
- 11.6 Others
- 12 Patent Analysis
- 12.1 Analysis by Type of Patent
- 12.2 Analysis by Publication year
- 12.3 Analysis by Issuing Authority
- 12.4 Analysis by Patent Age
- 12.5 Analysis by CPC Analysis
- 12.6 Analysis by Patent Valuation
- 12.7 Analysis by Key Players
- 13 Grants Analysis
- 13.1 Analysis by year
- 13.2 Analysis by Amount Awarded
- 13.3 Analysis by Issuing Authority
- 13.4 Analysis by Grant Application
- 13.5 Analysis by Funding Institute
- 13.6 Analysis by NIH Departments
- 13.7 Analysis by Recipient Organization
- 14 Funding Analysis
- 14.1 Analysis by Funding Instances
- 14.2 Analysis by Type of Funding
- 14.3 Analysis by Funding Amount
- 14.4 Analysis by Leading Players
- 14.5 Analysis by Leading Investors
- 14.6 Analysis by Geography
- 15 Partnership and Collaborations Analysis
- 15.1 Analysis by Partnership Instances
- 15.2 Analysis by Type of Partnership
- 15.3 Analysis by Leading Players
- 15.4 Analysis by Geography
- 16 Regulatory Framework
- 16.1 Regulatory Overview
- 16.1.1 US FDA
- 16.1.2 EU EMA
- 16.1.3 INDIA CDSCO
- 16.1.4 JAPAN PMDA
- 16.1.5 Others
- 17 Supplier Landscape
- 17.1 Abbott
- 17.1.1 Financial Analysis
- 17.1.2 Product Portfolio
- 17.1.3 Demographic Reach and Achievements
- 17.1.4 Mergers and Acquisition
- 17.1.5 Certifications
- 17.2 Agilent Technologies Inc.
- 17.2.1 Financial Analysis
- 17.2.2 Product Portfolio
- 17.2.3 Demographic Reach and Achievements
- 17.2.4 Mergers and Acquisition
- 17.2.5 Certifications
- 17.3 Danaher
- 17.3.1 Financial Analysis
- 17.3.2 Product Portfolio
- 17.3.3 Demographic Reach and Achievements
- 17.3.4 Mergers and Acquisition
- 17.3.5 Certifications
- 17.4 BD
- 17.4.1 Financial Analysis
- 17.4.2 Product Portfolio
- 17.4.3 Demographic Reach and Achievements
- 17.4.4 Mergers and Acquisition
- 17.4.5 Certifications
- 17.5 Bio-Rad Laboratories Inc.
- 17.5.1 Financial Analysis
- 17.5.2 Product Portfolio
- 17.5.3 Demographic Reach and Achievements
- 17.5.4 Mergers and Acquisition
- 17.5.5 Certifications
- 17.6 General Electric
- 17.6.1 Financial Analysis
- 17.6.2 Product Portfolio
- 17.6.3 Demographic Reach and Achievements
- 17.6.4 Mergers and Acquisition
- 17.6.5 Certifications
- 17.7 bioMérieux SA
- 17.7.1 Financial Analysis
- 17.7.2 Product Portfolio
- 17.7.3 Demographic Reach and Achievements
- 17.7.4 Mergers and Acquisition
- 17.7.5 Certifications
- 17.8 LONZA
- 17.8.1 Financial Analysis
- 17.8.2 Product Portfolio
- 17.8.3 Demographic Reach and Achievements
- 17.8.4 Mergers and Acquisition
- 17.8.5 Certifications
- 17.9 F. Hoffmann-La Roche Ltd.
- 17.9.1 Financial Analysis
- 17.9.2 Product Portfolio
- 17.9.3 Demographic Reach and Achievements
- 17.9.4 Mergers and Acquisition
- 17.9.5 Certifications
- 17.10 Hoefer, Inc.
- 17.10.1 Financial Analysis
- 17.10.2 Product Portfolio
- 17.10.3 Demographic Reach and Achievements
- 17.10.4 Mergers and Acquisition
- 17.10.5 Certifications
- 17.11 PerkinElmer Inc.
- 17.11.1 Financial Analysis
- 17.11.2 Product Portfolio
- 17.11.3 Demographic Reach and Achievements
- 17.11.4 Mergers and Acquisition
- 17.11.5 Certifications
- 17.12 Merck KGaA
- 17.12.1 Financial Analysis
- 17.12.2 Product Portfolio
- 17.12.3 Demographic Reach and Achievements
- 17.12.4 Mergers and Acquisition
- 17.12.5 Certifications
- 17.13 Promega Corporation
- 17.13.1 Financial Analysis
- 17.13.2 Product Portfolio
- 17.13.3 Demographic Reach and Achievements
- 17.13.4 Mergers and Acquisition
- 17.13.5 Certifications
- 17.14 Quality Biological
- 17.14.1 Financial Analysis
- 17.14.2 Product Portfolio
- 17.14.3 Demographic Reach and Achievements
- 17.14.4 Mergers and Acquisition
- 17.14.5 Certifications
- 17.15 Siemens
- 17.15.1 Financial Analysis
- 17.15.2 Product Portfolio
- 17.15.3 Demographic Reach and Achievements
- 17.15.4 Mergers and Acquisition
- 17.15.5 Certifications
- 17.16 Bio-Techne
- 17.16.1 Financial Analysis
- 17.16.2 Product Portfolio
- 17.16.3 Demographic Reach and Achievements
- 17.16.4 Mergers and Acquisition
- 17.16.5 Certifications
- 17.17 TAKARA HOLDINGS INC.
- 17.17.1 Financial Analysis
- 17.17.2 Product Portfolio
- 17.17.3 Demographic Reach and Achievements
- 17.17.4 Mergers and Acquisition
- 17.17.5 Certifications
- 17.18 Sysmex Corporation
- 17.18.1 Financial Analysis
- 17.18.2 Product Portfolio
- 17.18.3 Demographic Reach and Achievements
- 17.18.4 Mergers and Acquisition
- 17.18.5 Certifications
- 17.19 Tosoh Corporation
- 17.19.1 Financial Analysis
- 17.19.2 Product Portfolio
- 17.19.3 Demographic Reach and Achievements
- 17.19.4 Mergers and Acquisition
- 17.19.5 Certifications
- 17.20 Olympus Corporation
- 17.20.1 Financial Analysis
- 17.20.2 Product Portfolio
- 17.20.3 Demographic Reach and Achievements
- 17.20.4 Mergers and Acquisition
- 17.20.5 Certifications
- 18 Global Biotechnology Reagents Market - Distribution Model (Additional Insight)
- 18.1 Overview
- 18.2 Potential Distributors
- 18.3 Key Parameters for Distribution Partner Assessment
- 19 Key Opinion Leaders (KOL) Insights (Additional Insight)
- 20 Company Competitiveness Analysis (Additional Insight)
- 20.1 Very Small Companies
- 20.2 Small Companies
- 20.3 Mid-Sized Companies
- 20.4 Large Companies
- 20.5 Very Large Companies
- 21 Payment Methods (Additional Insight)
- 21.1 Government Funded
- 21.2 Private Insurance
- 21.3 Out-of-Pocket
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
